Phibro Animal Health (PAHC) Tops Q2 EPS by 5c; updates guidance

Phibro Animal Health (NASDAQ: PAHC) reported Q2 EPS of $0.33, $0.05 better than the analyst estimate of $0.28. Revenue for the quarter came in at $249.9 million versus the consensus estimate of $240.93 million.

GUIDANCE:

Phibro Animal Health sees FY2024 EPS of $1.04-$1.16, versus the consensus of $1.07. Phibro Animal Health sees FY2024 revenue of $980-1020 million, versus the consensus of $988.1 million.

For earnings history and earnings-related data on Phibro Animal Health (PAHC) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• MIND Technology (MIND) Misses Q1 EPS by 5c
• Oxford Industries (OXM) Tops Q1 EPS by 12c; Offers Outlook